Clinical Trials Logo

Alcohol Drinking clinical trials

View clinical trials related to Alcohol Drinking.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06457113 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Emotional Attention Bias Modification and Targeted Memory Reactivation in Alcohol Use Disorder

Start date: June 30, 2024
Phase: N/A
Study type: Interventional

Through this protocol, researchers examine whether Targeted Memory Reactivation (TMR), a technique used to enhance memory, can augment the control of craving levels in patients with Alcohol Use Disorder by enhancing positive emotional attention bias modification.

NCT ID: NCT06446479 Not yet recruiting - Clinical trials for Cannabis Use Disorder

Effects of THC on Alcohol Consumption and Neural Correlates of Reward

Start date: July 1, 2024
Phase: Phase 2
Study type: Interventional

Alcohol and cannabis are often used together such that their effects overlap, but little is known about the neural mechanisms that underlie simultaneous use. High doses of THC have not been well-studied in the laboratory, and it is unclear how high doses of THC may impact alcohol consumption patterns. The proposed study will explore the effects of oral THC (20mg dronabinol) vs. placebo on neural reward, alcohol self-administration and naturalistic co-use patterns.

NCT ID: NCT06444295 Not yet recruiting - Alcohol Drinking Clinical Trials

Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault

Start date: June 15, 2024
Phase: N/A
Study type: Interventional

The goal of this study is to find the most effective and efficient version of the THRIVE app. The THRIVE app is the first app-based preventative intervention that has been found to reduce alcohol misuse and posttraumatic stress in people who have recently experienced sexual assault. In this trial, participants are randomly assigned to receive different versions of the THRIVE app to compare their impact. The THRIVE app is currently only available to participants in this study.

NCT ID: NCT06444243 Not yet recruiting - Depression Clinical Trials

Psilocybin-assisted Therapy for Alcohol Use Disorder

Start date: September 2024
Phase: Phase 2
Study type: Interventional

To explore the effectiveness of psilocybin-assisted therapy on reducing alcohol consumption in a double-blind, randomised, phase II clinical trial.

NCT ID: NCT06442800 Not yet recruiting - Alcohol Drinking Clinical Trials

Impacts of Alcohol Warning Labels: An Online Experiment

Start date: June 2024
Phase: N/A
Study type: Interventional

The goal of this experiment is to examine responses to alcohol warning messages about 10 different topics among US adult alcohol consumers. The main questions this experiment aims to answer are: Which warning topics make alcohol consumers in the US want to drink less alcohol? Which warning topics remind alcohol consumers in the US of alcohol's harms? Which warning topics help alcohol consumers in the US learn something new? There will be a total of 20 alcohol messages, 2 messages for each of the 10 topics. For each topic, participants will be randomly assigned to 1 of the 2 messages so that they view a total of 10 alcohol messages. All 10 messages will be shown in random order. Participants will rate each message on how much it makes them want to drink less alcohol, reminds them that drinking can be harmful, and teaches them something new.

NCT ID: NCT06432361 Not yet recruiting - Alcohol Drinking Clinical Trials

Resource Allocation for Alcohol

Start date: March 2025
Phase: N/A
Study type: Interventional

A total of 150 young adults (ages 21-29) will be randomized to receive a brief alcohol intervention (intended to reduce alcohol-related resource allocation (e.g., time and money spent on alcohol), alcohol consumption, and alcohol related consequences) or an assessment only control condition. All participants will complete a 3 week monitoring period of daily surveys assessing time spent in various domains, alcohol use, personal goals, and money spent on alcohol and substance-free activities. Those in the intervention condition will receive weekly personalized information summarizing the previous week's resource allocation. All participants will complete a 1 and 3 month follow up survey. Participants can earn up to $126 for completing all study components.

NCT ID: NCT06422299 Not yet recruiting - Alcohol Drinking Clinical Trials

Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Young Adult Couples

Start date: July 15, 2026
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to develop and test a brief online intervention to reduce alcohol and cannabis misuse and improve healthy relationship skills among young adult couples. The main questions it aims to answer are: - Will the intervention be feasible and acceptable to young adult couples? - Will the intervention demonstrate initial efficacy in reducing risky substance use and increasing relationship functioning? Eligible couples will complete a virtual baseline session and be randomized to intervention condition (online intervention with 3-5 weeks of self-paced modules) or control condition (no intervention). Couples will complete two follow-up surveys (post-assessment - approximately 5 weeks after baseline, 3-month). Couples in the control condition will be offered the intervention after 3-month follow-up. Researchers will compare intervention and control groups to see if there there is a difference between the groups on substance misuse and relationship functioning at post-assessment and 3-month follow-up.

NCT ID: NCT06420050 Not yet recruiting - Heavy Drinking Clinical Trials

Testing a Novel Instagram Intervention for Heavy Alcohol Use

Start date: May 20, 2024
Phase: N/A
Study type: Interventional

This project aims to test the efficacy of an Instagram-based intervention for reducing heavy alcohol use. More specifically, the investigators will use a randomized controlled design to analyze differences in alcohol use and alcohol-related outcomes (e.g., alcohol-related consequences, etc.) as well as differences in the use of protective behavioral strategies and mindfulness practices. Participants (80 Prolific users who report binge drinking) will be randomly assigned to 1 of 3 conditions: intervention or control. Those who are randomized to the intervention condition will be invited to follow study Instagram pages, and those who are randomized to the control condition will be invited to complete the assessments only. The investigators hypothesize that there will be greater reductions in alcohol use, frequency, and consequences and greater frequency of use of mindfulness exercises and protective behavioral strategies among those in the intervention condition as compared to those in the control condition.

NCT ID: NCT06419647 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Tracking Mood: The Effects of Daily Mood Tracking VAS on Alcohol Consumption in Adult Heavy Drinkers

Start date: May 2024
Phase: N/A
Study type: Interventional

The study aims to investigate the effects that mood tracking may have on the alcohol consumption of adults who consume more than 20 UK units of alcohol per week, classifying as high-risk drinkers. The intervention group will track their mood on a daily basis with a visual analogue scale, while the control group will report their daily time spent online. The hypothesis, based on a series of prior pilot studies on alcohol tracking methods, is that mood tracking can reduce alcohol consumption in high-risk drinkers and therefore be a suitable addition to interventions related to decreasing alcohol consumption in heavy drinkers. The study will be conducted online through the Prolific platform.

NCT ID: NCT06415721 Not yet recruiting - Clinical trials for Alcohol Use Disorder

Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

Alcohol Use Disorders are currently positioned as the third leading cause of preventable death in the United States, constituting a humanitarian crisis with substantial financial burden on society and medical facilities. While several pharmacological interventions exist, 60% of individuals who seek these treatments relapse to alcohol within 6 months. These high relapse rates are due in part to elevated brain response to alcohol cues in the environment. This study seeks to evaluate the efficacy of one session of functional Magnetic Resonance Imaging (fMRI) guided transcranial magnetic stimulation (TMS) as a strategy to reduce brain reactivity to alcohol cues.